Phillips Catherine M, Perry Ivan J
HRB Centre for Diet and Health Research, Dept. of Epidemiology and Public Health, University College Cork, Cork, Ireland.
HRB Centre for Diet and Health Research, Dept. of Epidemiology and Public Health, University College Cork, Cork, Ireland.
Atherosclerosis. 2015 Oct;242(2):399-406. doi: 10.1016/j.atherosclerosis.2015.07.040. Epub 2015 Jul 23.
No data regards lipoprotein particle profiles in obese and non-obese metabolic health subtypes exist. We characterised lipoprotein size, particle and subclass concentrations among metabolically healthy and unhealthy obese and non-obese adults.
Cross-sectional sample of 1834 middle-aged Irish adults were classified as obese (BMI ≥30 kg/m(2)) and non-obese (BMI <30 kg/m(2)). Metabolic health was defined using three metabolic health definitions based on various cardiometabolic abnormalities including metabolic syndrome criteria, insulin resistance and inflammation. Lipoprotein size, particle and subclass concentrations were determined using nuclear magnetic resonance (NMR) spectroscopy.
Lipoprotein profiling identified a range of adverse phenotypes among the metabolically unhealthy individuals, regardless of BMI and metabolic health definition, including increased numbers of small low density lipoprotein (LDL) (P < 0.001) and high density lipoprotein (HDL) particles (P < 0.001), large very low density lipoprotein (VLDL) particles (P < 0.001) and greater lipoprotein related insulin resistance (P < 0.001). The most significant predictors of metabolic health were lower numbers of large VLDL (ORs 2.72-3.13 and 2.49-3.86, P < 0.05 among obese and non-obese individuals, respectively) and small dense LDL particles (ORs 1.78-2.39 and 1.50-1.94, P < 0.05) and higher numbers of large LDL (ORs 1.82-2.66 and 2.84-3.27, P < 0.05) and large HDL particles (ORs 1.88-2.58 and 1.81-3.49, P < 0.05).
Metabolically healthy adults displayed favourable lipoprotein particle profiles, irrespective of BMI and metabolic health definition. These findings underscore the importance of maintaining a healthy lipid profile in the context of overall cardiometabolic health.
目前尚无关于肥胖和非肥胖代谢健康亚型中脂蛋白颗粒谱的数据。我们对代谢健康和不健康的肥胖及非肥胖成年人的脂蛋白大小、颗粒及亚类浓度进行了特征分析。
对1834名爱尔兰中年成年人进行横断面抽样,将其分为肥胖(BMI≥30kg/m²)和非肥胖(BMI<30kg/m²)。基于包括代谢综合征标准、胰岛素抵抗和炎症在内的各种心脏代谢异常,使用三种代谢健康定义来界定代谢健康状况。采用核磁共振(NMR)光谱法测定脂蛋白大小、颗粒及亚类浓度。
脂蛋白分析在代谢不健康个体中识别出一系列不良表型,无论BMI和代谢健康定义如何,包括小低密度脂蛋白(LDL)颗粒数量增加(P<0.001)、高密度脂蛋白(HDL)颗粒数量增加(P<0.001)、大极低密度脂蛋白(VLDL)颗粒数量增加(P<0.001)以及脂蛋白相关胰岛素抵抗增强(P<0.001)。代谢健康的最显著预测因素是大VLDL颗粒数量减少(肥胖和非肥胖个体中OR分别为2.72 - 3.13和2.49 - 3.86,P<0.05)以及小而密LDL颗粒数量减少(OR分别为1.78 - 2.39和1.50 - 1.94,P<0.05),还有大LDL颗粒数量增加(OR分别为1.82 - 2.66和2.84 - 3.27,P<0.05)以及大HDL颗粒数量增加(OR分别为1.88 - 2.58和1.81 - 3.49,P<0.05)。
无论BMI和代谢健康定义如何,代谢健康的成年人都呈现出良好的脂蛋白颗粒谱。这些发现强调了在整体心脏代谢健康背景下维持健康血脂谱的重要性。